Company Filing History:
Years Active: 1997
Title: Herwig Reichl: Innovator in Pharmaceutical Compositions
Introduction
Herwig Reichl is a notable inventor based in Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of histamine-induced diseases. His work focuses on developing innovative compositions that can improve patient outcomes.
Latest Patents
Herwig Reichl holds a patent for "Diaminooxidase-Containing Pharmaceutical Compositions." This invention provides a pharmaceutical composition for the treatment of histamine-induced diseases. The composition includes a pharmaceutically acceptable carrier or diluent and diaminooxidase. It is designed to be administered in a gastric-acid-protected dosage form for oral or peroral administration. This composition can be used to treat various clinical symptoms, including urticaria, atopic dermatitis, and scombrotoxism, or for removing histamine from the gastrointestinal tract.
Career Highlights
Herwig Reichl is associated with Sciotec Diagnostic Technologies GmbH, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in developing effective treatments has positioned him as a valuable asset in his field.
Collaborations
Herwig has collaborated with notable colleagues, including Albert Missbichler and Franz Gabor. These partnerships have contributed to the advancement of his research and the development of new pharmaceutical technologies.
Conclusion
Herwig Reichl's contributions to pharmaceutical compositions demonstrate his commitment to improving healthcare solutions. His innovative work continues to impact the treatment of histamine-induced diseases, showcasing the importance of research and development in the medical field.